Alex Yang
Vermogen: 46 M $ op 31-08-2026
Vermogen: 46 M $ op 31-08-2026
Alex Yang is currently Chairman & Chief Executive Officer at Polaryx Therapeutics, Inc. since 2023, Chairman & Chief Executive Officer at Epygenix Therapeutics, Inc., and Chief Executive Officer at Mstone Partners Hong Kong Ltd. Formerly, Mr. Yang was Managing Partner at Kim & Chang.
Education includes undergraduate studies at State University of New York at Binghamton and graduate studies at New York University School of Law.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 27-07-2026 | 22.833.249 ( 45,81% ) | 46 M $ | 31-08-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| POLARYX THERAPEUTICS, INC. | Algemeen Directeur | 01-03-2023 |
Epygenix Therapeutics, Inc.
Epygenix Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for neurological disorders | Algemeen Directeur | - |
Mstone Partners Hong Kong Ltd. | Algemeen Directeur | - |
| Bedrijven | Functie | Einde |
|---|---|---|
Kim & Chang
Kim & Chang Miscellaneous Commercial ServicesCommercial Services Provides legal services | Corporate Officer/Principal | - |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 6 |
|---|---|
Kim & Chang
Kim & Chang Miscellaneous Commercial ServicesCommercial Services Provides legal services | Commercial Services |
State University of New York at Binghamton
State University of New York at Binghamton Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
New York University School of Law
New York University School of Law Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Mstone Partners Hong Kong Ltd. | |
Epygenix Therapeutics, Inc.
Epygenix Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for neurological disorders | Health Technology |
Polaryx Therapeutics, Inc.
Polaryx Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical-stage biotechnology company that engages in discovery, development and commercialization of novel, disease-modifying therapies for rare, pediatric lysosomal storage disorders | Commercial Services |
Kies jouw editie
Alle financiële informatie op nationaal niveau